humanized glp-1 receptor knock-in mouse Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP -1 despite enzymatic cleavage of its C-terminal end Human GLP1R mice | Gene

They require long-term use to maintain results, and stopping these medications too soon can lead to weight gain or issues with blood sugar control

Huang, F

[76] found no evidence of increased risk of suicidal ideation and self-injury associated with GLP-1 RAs compared to SGLT-2 inhibitors in individuals with T2DM and obesity, based on data from the Valencia Health System Integrated Database (VID) (per-protocol analysis: HR, 1.04

pros and cons of GLP1 medications vs lifestyle programs for losing weight

The FDA has been relatively progressive in approving GLP-1 products for expanded indications, including cardiovascular risk reduction

Lowering the cost of GLP-1s for people could have a significant impact on their health